Although the molecular mechanisms behind the role of TIMP1 for ovarian cancer proliferation and dissemination should be studied in more detail, our results open an interesting line of research, indicating its value as a potential therapeutic target. This evidence concerns the gene TIMP1 and ovarian cancer.